GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (NSE:BIOCON) » Definitions » Long-Term Debt

Biocon (NSE:BIOCON) Long-Term Debt : ₹129,324 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Biocon Long-Term Debt?

Biocon's Long-Term Debt for the quarter that ended in Mar. 2024 was ₹129,324 Mil.

Biocon's quarterly Long-Term Debt declined from Sep. 2023 (₹150,073 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹129,324 Mil).

Biocon's annual Long-Term Debt increased from Mar. 2022 (₹39,985 Mil) to Mar. 2023 (₹152,905 Mil) but then declined from Mar. 2023 (₹152,905 Mil) to Mar. 2024 (₹129,324 Mil).

Biocon Long-Term Debt Historical Data

The historical data trend for Biocon's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon Long-Term Debt Chart

Biocon Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,222.00 29,616.00 39,985.00 152,905.00 129,324.00

Biocon Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 152,905.00 - 150,073.00 - 129,324.00

Biocon  (NSE:BIOCON) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Biocon Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Biocon's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocon (NSE:BIOCON) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (NSE:BIOCON) » Definitions » Long-Term Debt
Comparable Companies
BOM:539268 BOM:543960 BOM:540701 BOM:543434 NSE:ZOTA BOM:531349 NSE:BALAXI BOM:500259 BOM:524717 BOM:532890 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 HKSE:02269 MRNA XBRU:ARGX BNTX
Traded in Other Exchanges
532523:India
Address
20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560 100
Website
https://www.biocon.com
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.

Biocon (NSE:BIOCON) Headlines

No Headlines